NASDAQ:NURO

NeuroMetrix News Headlines

$18.15
-2.82 (-13.45 %)
(As of 07/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$18.00
$23.75
50-Day Range
$2.90
$24.73
52-Week Range
$1.39
$38.75
Volume16.98 million shs
Average Volume3.50 million shs
Market Capitalization$69.02 million
P/E RatioN/A
Dividend YieldN/A
Beta2.81

NeuroMetrix (NASDAQ NURO) News Headlines Today

SourceHeadline
NeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of Fibromyalgia - Yahoo FinanceNeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of Fibromyalgia - Yahoo Finance
finance.yahoo.com - July 26 at 6:22 PM
NeuroMetrix Announces Peer-Reviewed Publication Of Randomized Controlled Trial Of Its Wearable Neurostimulation Technology For Treatment Of Fibromyalgia - BenzingaNeuroMetrix Announces Peer-Reviewed Publication Of Randomized Controlled Trial Of Its Wearable Neurostimulation Technology For Treatment Of Fibromyalgia - Benzinga
benzinga.com - July 26 at 1:22 PM
NeuroMetrix gains on trial results of neurostimulation device Quell for fibromyalgia - Seeking AlphaNeuroMetrix gains on trial results of neurostimulation device Quell for fibromyalgia - Seeking Alpha
seekingalpha.com - July 26 at 1:22 PM
NeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of FibromyalgiaNeuroMetrix Announces Peer-Reviewed Publication of a Randomized Controlled Trial of its Wearable Neurostimulation Technology for Treatment of Fibromyalgia
finance.yahoo.com - July 26 at 1:22 PM
NeuroMetrix (NASDAQ:NURO) Stock Price Crosses Above 200-Day Moving Average of $0.00NeuroMetrix (NASDAQ:NURO) Stock Price Crosses Above 200-Day Moving Average of $0.00
americanbankingnews.com - July 24 at 2:30 AM
NeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenue - Seeking AlphaNeuroMetrix stock joins Reddit-driven rally with 60% rise in Q2 revenue - Seeking Alpha
seekingalpha.com - July 23 at 6:30 PM
Form 8-K NeuroMetrix, Inc. For: Jul 22 - StreetInsider.comForm 8-K NeuroMetrix, Inc. For: Jul 22 - StreetInsider.com
streetinsider.com - July 23 at 7:54 AM
Form 10-Q NeuroMetrix, Inc. For: Jun 30 - StreetInsider.comForm 10-Q NeuroMetrix, Inc. For: Jun 30 - StreetInsider.com
streetinsider.com - July 23 at 7:54 AM
Shares of NeuroMetrix more than double after positive FDA news - FortuneShares of NeuroMetrix more than double after positive FDA news - Fortune
fortune.com - July 22 at 10:51 PM
NeuroMetrix Reports Q2 2021 Financial Results - Yahoo FinanceNeuroMetrix Reports Q2 2021 Financial Results - Yahoo Finance
finance.yahoo.com - July 22 at 12:50 PM
NeuroMetrix Stock Skyrockets On FDA Update: Technical Levels To Watch - Benzinga - BenzingaNeuroMetrix Stock Skyrockets On FDA Update: Technical Levels To Watch - Benzinga - Benzinga
benzinga.com - July 22 at 7:49 AM
NeuroMetrix Reports Q2 2021 Financial Results - GlobeNewswireNeuroMetrix Reports Q2 2021 Financial Results - GlobeNewswire
globenewswire.com - July 22 at 7:49 AM
NeuroMetrix Reports Q2 2021 Financial ResultsNeuroMetrix Reports Q2 2021 Financial Results
finance.yahoo.com - July 22 at 7:49 AM
NeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia - BenzingaNeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia - Benzinga
benzinga.com - July 22 at 12:53 AM
Chembio Diagnostics, NeuroMetrix leads healthcare gainers; NeuroBo Pharmaceuticals, Healthcare Services among major losers - Seeking AlphaChembio Diagnostics, NeuroMetrix leads healthcare gainers; NeuroBo Pharmaceuticals, Healthcare Services among major losers - Seeking Alpha
seekingalpha.com - July 21 at 2:41 PM
Why NeuroMetrix Shares Are Skyrocketing Today - Benzinga - BenzingaWhy NeuroMetrix Shares Are Skyrocketing Today - Benzinga - Benzinga
benzinga.com - July 21 at 2:41 PM
Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson - TheStreetPremarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson - TheStreet
thestreet.com - July 21 at 9:41 AM
Takeda agrees to supply additional 50 mln Moderna COVID-19 vaccines to Japan - Yahoo FinanceTakeda agrees to supply additional 50 mln Moderna COVID-19 vaccines to Japan - Yahoo Finance
finance.yahoo.com - July 21 at 4:40 AM
NeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia - Yahoo FinanceNeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia - Yahoo Finance
finance.yahoo.com - July 21 at 4:40 AM
3 Penny Stocks Rocketing Higher on Space Race and S&P 500 Gain - StreetInsider.com3 Penny Stocks Rocketing Higher on Space Race and S&P 500 Gain - StreetInsider.com
streetinsider.com - July 20 at 10:22 PM
Mid-Day Market Update: HCA Healthcare Surges On Upbeat Results; Ardelyx Shares Slide - Markets InsiderMid-Day Market Update: HCA Healthcare Surges On Upbeat Results; Ardelyx Shares Slide - Markets Insider
markets.businessinsider.com - July 20 at 5:22 PM
Mid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher - BenzingaMid-Afternoon Market Update: Dow Jumps Over 600 Points; NeuroMetrix Shares Spike Higher - Benzinga
benzinga.com - July 20 at 5:22 PM
NeuroMetrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boost - MarketWatchNeuroMetrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boost - MarketWatch
marketwatch.com - July 20 at 5:22 PM
NeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For FibromyalgiaNeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia
finance.yahoo.com - July 20 at 5:22 PM
NeuroMetrix Soars on FDA Breakthrough Status for Fibromyalgia DeviceNeuroMetrix Soars on FDA 'Breakthrough Status' for Fibromyalgia Device
finance.yahoo.com - July 20 at 5:22 PM
Shares of NeuroMetrix more than double after positive FDA newsShares of NeuroMetrix more than double after positive FDA news
finance.yahoo.com - July 20 at 5:22 PM
NeuroMetrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boostNeuroMetrix stock more than triples on massive volume after fibromyalgia treatment gets FDA boost
finance.yahoo.com - July 20 at 5:22 PM
Pre-Open Stock Movers 07/20: (IMNM) (NURO) (PTON) Higher; (ARDX) (PPG) (RKT) Lower (more...) - StreetInsider.comPre-Open Stock Movers 07/20: (IMNM) (NURO) (PTON) Higher; (ARDX) (PPG) (RKT) Lower (more...) - StreetInsider.com
streetinsider.com - July 20 at 12:21 PM
NeuroMetrix Says Receives FDA Breakthrough Device Designation For Treatment Of Fibromyalgia With Its Wearable Neurostimulation Technology - BenzingaNeuroMetrix Says Receives FDA Breakthrough Device Designation For Treatment Of Fibromyalgia With Its Wearable Neurostimulation Technology - Benzinga
benzinga.com - July 20 at 12:21 PM
NeuroBo Pharmaceuticals, NeuroMetrix leads healthcare gainers; Ardelyx, Allied Healthcare Products among major losers - Seeking AlphaNeuroBo Pharmaceuticals, NeuroMetrix leads healthcare gainers; Ardelyx, Allied Healthcare Products among major losers - Seeking Alpha
seekingalpha.com - July 20 at 12:21 PM
NeuroMetrix Receives FDA Breakthrough Device Designation - GlobeNewswireNeuroMetrix Receives FDA Breakthrough Device Designation - GlobeNewswire
globenewswire.com - July 20 at 12:21 PM
NeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation TechnologyNeuroMetrix Receives FDA Breakthrough Device Designation for Treatment of Fibromyalgia with its Wearable Neurostimulation Technology
finance.yahoo.com - July 20 at 12:21 PM
NeuroMetrix (NURO) to Release Quarterly Earnings on ThursdayNeuroMetrix (NURO) to Release Quarterly Earnings on Thursday
americanbankingnews.com - July 16 at 8:57 AM
NeuroMetrix, Inc. Announces Date for Second Quarter 2021 Financial Results Conference CallNeuroMetrix, Inc. Announces Date for Second Quarter 2021 Financial Results Conference Call
finance.yahoo.com - July 15 at 12:41 PM
NeuroMetrix (NASDAQ:NURO) Stock Price Passes Above 200-Day Moving Average of $0.00NeuroMetrix (NASDAQ:NURO) Stock Price Passes Above 200-Day Moving Average of $0.00
americanbankingnews.com - July 15 at 2:00 AM
NeuroMetrix, Inc. (NASDAQ:NURO) Sees Large Decrease in Short InterestNeuroMetrix, Inc. (NASDAQ:NURO) Sees Large Decrease in Short Interest
americanbankingnews.com - July 7 at 4:00 AM
Short Interest in NeuroMetrix, Inc. (NASDAQ:NURO) Decreases By 15.7%Short Interest in NeuroMetrix, Inc. (NASDAQ:NURO) Decreases By 15.7%
americanbankingnews.com - July 5 at 11:50 AM
12 Health Care Stocks Moving In Tuesdays After-Market Session - Benzinga - Benzinga12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga - Benzinga
benzinga.com - June 15 at 11:27 PM
NeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder - GlobeNewswireNeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder - GlobeNewswire
globenewswire.com - June 15 at 1:26 PM
NeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled TrialNeuroMetrix Reports that Quell® Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial
finance.yahoo.com - June 15 at 1:26 PM
Form SD NeuroMetrix, Inc. - StreetInsider.comForm SD NeuroMetrix, Inc. - StreetInsider.com
streetinsider.com - June 15 at 8:25 AM
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences - Yahoo FinanceNeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences - Yahoo Finance
finance.yahoo.com - June 11 at 6:49 PM
NeuroMetrixs Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial - Yahoo FinanceNeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial - Yahoo Finance
finance.yahoo.com - June 11 at 1:48 PM
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences - GlobeNewswireNeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences - GlobeNewswire
globenewswire.com - June 9 at 8:21 AM
NeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine ConferencesNeuroMetrix Announces That Top-Line Results from a Randomized Controlled Trial of Quell® for Treatment of Fibromyalgia to be Presented at Two Upcoming Pain Medicine Conferences
finance.yahoo.com - June 9 at 8:21 AM
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - NasdaqToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - Nasdaq
nasdaq.com - May 22 at 11:53 PM
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - Investorplace.comToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday - Investorplace.com
investorplace.com - May 21 at 11:38 AM
Global Neurostimulation Technologies Market 2021-2026 with Focus on Spinal Cord Stimulation (SCS) Devices & Deep Brain Stimulation (DBS) Devices - ResearchAndMarkets.com - Business WireGlobal Neurostimulation Technologies Market 2021-2026 with Focus on Spinal Cord Stimulation (SCS) Devices & Deep Brain Stimulation (DBS) Devices - ResearchAndMarkets.com - Business Wire
businesswire.com - May 20 at 10:40 PM
Ultivue Announces New Executive Team Member - Business WireUltivue Announces New Executive Team Member - Business Wire
businesswire.com - April 22 at 12:38 PM
NeuroMetrix, Inc.s (NURO) CEO Shai Gozani on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaNeuroMetrix, Inc.'s (NURO) CEO Shai Gozani on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - April 22 at 12:38 PM
This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.